My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 98

    1.

    Inflammation in Alzheimer's disease: relevance to pathogenesis and therapy.

    Zotova E, Nicoll JA, Kalaria R, Holmes C, Boche D.

    Alzheimers Res Ther. 2010 Jan 22;2(1):1. [Epub ahead of print]PMID: 20122289 [PubMed - as supplied by publisher]Related articlesFree article

    2.

    Toward an early diagnosis and treatment of Alzheimer's disease.

    Nordberg A.

    Int Psychogeriatr. 2003 Sep;15(3):223-37.PMID: 14756159 [PubMed - indexed for MEDLINE]Related articles

    3.

    Role of the immune system in the pathogenesis, prevention and treatment of Alzheimer's disease.

    Blasko I, Grubeck-Loebenstein B.

    Drugs Aging. 2003;20(2):101-13. Review.PMID: 12534311 [PubMed - indexed for MEDLINE]Related articles

    4.

    Always around, never the same: pathways of amyloid beta induced neurodegeneration throughout the pathogenic cascade of Alzheimer's disease.

    Hoozemans JJ, Chafekar SM, Baas F, Eikelenboom P, Scheper W.

    Curr Med Chem. 2006;13(22):2599-605. Review.PMID: 17017913 [PubMed - indexed for MEDLINE]Related articles

    6.

    M1 muscarinic agonists can modulate some of the hallmarks in Alzheimer's disease: implications in future therapy.

    Fisher A, Pittel Z, Haring R, Bar-Ner N, Kliger-Spatz M, Natan N, Egozi I, Sonego H, Marcovitch I, Brandeis R.

    J Mol Neurosci. 2003;20(3):349-56. Review.PMID: 14501019 [PubMed - indexed for MEDLINE]Related articles

    7.

    Importance of immunological and inflammatory processes in the pathogenesis and therapy of Alzheimer's disease.

    Popović M, Caballero-Bleda M, Puelles L, Popović N.

    Int J Neurosci. 1998 Sep;95(3-4):203-36. Review.PMID: 9777440 [PubMed - indexed for MEDLINE]Related articles

    8.

    Neuroinflammatory perspectives on the two faces of Alzheimer's disease.

    Eikelenboom P, van Gool WA.

    J Neural Transm. 2004 Mar;111(3):281-94. Epub 2003 Dec 3. Review.PMID: 14991455 [PubMed - indexed for MEDLINE]Related articles

    9.

    Novel 'inflammatory plaque' pathology in presenilin-1 Alzheimer's disease.

    Shepherd CE, Gregory GC, Vickers JC, Halliday GM.

    Neuropathol Appl Neurobiol. 2005 Oct;31(5):503-11.PMID: 16150121 [PubMed - indexed for MEDLINE]Related articles

    10.

    Vaccines for Alzheimer's disease: how close are we?

    Janus C.

    CNS Drugs. 2003;17(7):457-74. Review.PMID: 12751917 [PubMed - indexed for MEDLINE]Related articles

    11.

    Disease-modifying therapies in Alzheimer's disease: how far have we come?

    Hüll M, Berger M, Heneka M.

    Drugs. 2006;66(16):2075-93. Review.PMID: 17112302 [PubMed - indexed for MEDLINE]Related articles

    12.

    The role of the immune system in clearance of Abeta from the brain.

    Boche D, Nicoll JA.

    Brain Pathol. 2008 Apr;18(2):267-78. Review.PMID: 18363937 [PubMed - indexed for MEDLINE]Related articles

    13.

    Anti-inflammatory therapy in Alzheimer's disease: is hope still alive?

    van Gool WA, Aisen PS, Eikelenboom P.

    J Neurol. 2003 Jul;250(7):788-92. Review.PMID: 12883918 [PubMed - indexed for MEDLINE]Related articles

    14.

    Biochemical detection of Abeta isoforms: implications for pathogenesis, diagnosis, and treatment of Alzheimer's disease.

    Golde TE, Eckman CB, Younkin SG.

    Biochim Biophys Acta. 2000 Jul 26;1502(1):172-87. Review.PMID: 10899442 [PubMed - indexed for MEDLINE]Related articles

    15.

    Immunological aspects of alzheimer's disease: therapeutic implications.

    Hoozemans JJ, Rozemuller AJ, Veerhuis R, Eikelenboom P.

    BioDrugs. 2001;15(5):325-37. Review.PMID: 11437695 [PubMed - indexed for MEDLINE]Related articles

    16.

    Alzheimer's disease and inflammation: a review of cellular and therapeutic mechanisms.

    Halliday G, Robinson SR, Shepherd C, Kril J.

    Clin Exp Pharmacol Physiol. 2000 Jan-Feb;27(1-2):1-8. Review.PMID: 10696521 [PubMed - indexed for MEDLINE]Related articles

    17.

    Metal and inflammatory targets for Alzheimer's disease.

    Rogers JT, Lahiri DK.

    Curr Drug Targets. 2004 Aug;5(6):535-51. Review.PMID: 15270200 [PubMed - indexed for MEDLINE]Related articles

    18.

    The significance of neuroinflammation in understanding Alzheimer's disease.

    Eikelenboom P, Veerhuis R, Scheper W, Rozemuller AJ, van Gool WA, Hoozemans JJ.

    J Neural Transm. 2006 Nov;113(11):1685-95. Epub 2006 Oct 13. Review.PMID: 17036175 [PubMed - indexed for MEDLINE]Related articles

    19.

    Anti-inflammatory and Immune Therapy for Alzheimer's Disease: Current Status and Future Directions.

    Walker D, Lue LF.

    Curr Neuropharmacol. 2007 Dec;5(4):232-43.PMID: 19305740 [PubMed - in process]Related articlesFree article

    20.

    Effect of HMG-CoA reductase inhibitors on beta-amyloid peptide levels: implications for Alzheimer's disease.

    Höglund K, Blennow K.

    CNS Drugs. 2007;21(6):449-62. Review.PMID: 17521225 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data

    Write to the Help Desk